These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

384 related items for PubMed ID: 19026264

  • 1. Aripiprazole in schizophrenia patients with comorbid obsessive-compulsive symptoms: an open-label study of 15 patients.
    Glick ID, Poyurovsky M, Ivanova O, Koran LM.
    J Clin Psychiatry; 2008 Dec; 69(12):1856-9. PubMed ID: 19026264
    [Abstract] [Full Text] [Related]

  • 2. The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.
    Connor KM, Payne VM, Gadde KM, Zhang W, Davidson JR.
    J Clin Psychiatry; 2005 Jan; 66(1):49-51. PubMed ID: 15669888
    [Abstract] [Full Text] [Related]

  • 3. Successful treatment of comorbid obsessive-compulsive disorder with aripiprazole in three patients with bipolar disorder.
    Uguz F.
    Gen Hosp Psychiatry; 2010 Jan; 32(5):556-8. PubMed ID: 20851277
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aripiprazole for the prevention of relapse in stabilized patients with chronic schizophrenia: a placebo-controlled 26-week study.
    Pigott TA, Carson WH, Saha AR, Torbeyns AF, Stock EG, Ingenito GG, Aripiprazole Study Group.
    J Clin Psychiatry; 2003 Sep; 64(9):1048-56. PubMed ID: 14628980
    [Abstract] [Full Text] [Related]

  • 6. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder.
    Kane JM, Carson WH, Saha AR, McQuade RD, Ingenito GG, Zimbroff DL, Ali MW.
    J Clin Psychiatry; 2002 Sep; 63(9):763-71. PubMed ID: 12363115
    [Abstract] [Full Text] [Related]

  • 7. Obsessive-compulsive symptoms in patients with schizophrenia: Relationships with olanzapine pharmacological parameters, psychopathology, and quality of life.
    Wu TH, Chiu CC, Chen PY, Huang MC, Chen CH, Shen WW, Lu ML.
    Psychiatry Res; 2019 Jun; 276():1-5. PubMed ID: 30981095
    [Abstract] [Full Text] [Related]

  • 8. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY, Ham BJ, Kang RH, Paik JW, Hahn SW, Lee MS, Lee MS.
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
    [Abstract] [Full Text] [Related]

  • 9. Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.
    Pessina E, Albert U, Bogetto F, Maina G.
    Int Clin Psychopharmacol; 2009 Sep; 24(5):265-9. PubMed ID: 19629012
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A multicentre, randomized, naturalistic, open-label study between aripiprazole and standard of care in the management of community-treated schizophrenic patients Schizophrenia Trial of Aripiprazole: (STAR) study.
    Kerwin R, Millet B, Herman E, Banki CM, Lublin H, Pans M, Hanssens L, L'Italien G, McQuade RD, Beuzen JN.
    Eur Psychiatry; 2007 Oct; 22(7):433-43. PubMed ID: 17555947
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Lower levels of whole blood serotonin in obsessive-compulsive disorder and in schizophrenia with obsessive-compulsive symptoms.
    Ma N, Tan LW, Wang Q, Li ZX, Li LJ.
    Psychiatry Res; 2007 Feb 28; 150(1):61-9. PubMed ID: 17291595
    [Abstract] [Full Text] [Related]

  • 15. Amisulpride improves obsessive-compulsive symptoms in schizophrenia patients taking atypical antipsychotics: an open-label switch study.
    Kim SW, Shin IS, Kim JM, Yang SJ, Hwang MY, Yoon JS.
    J Clin Psychopharmacol; 2008 Jun 28; 28(3):349-52. PubMed ID: 18480697
    [No Abstract] [Full Text] [Related]

  • 16. Clozapine-induced obsessive-compulsive syndromes improve in combination with aripiprazole.
    Englisch S, Esslinger C, Inta D, Weinbrenner A, Peus V, Gutschalk A, Schirmbeck F, Zink M.
    Clin Neuropharmacol; 2009 Jun 28; 32(4):227-9. PubMed ID: 19644230
    [Abstract] [Full Text] [Related]

  • 17. Effect of aripiprazole on verbal memory and fluency in schizophrenic patients : results from the ESCAPE study.
    Bervoets C, Morrens M, Vansteelandt K, Kok F, de Patoul A, Halkin V, Pitsi D, Constant E, Peuskens J, Sabbe B.
    CNS Drugs; 2012 Nov 28; 26(11):975-82. PubMed ID: 23018547
    [Abstract] [Full Text] [Related]

  • 18. Long-term efficacy and safety of aripiprazole in patients with schizophrenia, schizophreniform disorder, or schizoaffective disorder: 26-week prospective study.
    Kwon JS, Jang JH, Kang DH, Yoo SY, Kim YK, Cho SJ, APLUS study group.
    Psychiatry Clin Neurosci; 2009 Feb 28; 63(1):73-81. PubMed ID: 19154213
    [Abstract] [Full Text] [Related]

  • 19. Effectiveness of aripiprazole in treating obsessive compulsive symptoms.
    Yang KC, Su TP, Chou YH.
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb 15; 32(2):585-6. PubMed ID: 18037548
    [No Abstract] [Full Text] [Related]

  • 20. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
    McQuade RD, Stock E, Marcus R, Jody D, Gharbia NA, Vanveggel S, Archibald D, Carson WH.
    J Clin Psychiatry; 2004 Feb 15; 65 Suppl 18():47-56. PubMed ID: 15600384
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.